Plaque Psoriasis

A Phase 3 Study to Evaluate the Efficacy and Safety of Induction and Maintenance Regimens of Brodalumab Compared With Placebo and Ustekinumab in Subjects With Moderate to Severe Plaque Psoriasis: AMAGINE-2.

Register Today!

Trial Information

Start DateOngoing
Trial Duration5 years
Number of VisitsVariable
Lead CRCJessica Richer
End DateTBD

For additional information
on this trial contact: